Adamis Pharmaceuticals Corp (ADMP)

[66Mustang]

Today is a terrible day. Other covid pharma companies have their names tied to announcements about their meds, like VRPX going from $4.XX Monday to a pre-market high of $37 today on one stupid announcement which says they are in the works but far behind Tempol's progress. Meanwhile, Tempol is marching forward with the NIH study, and every time NIH says Tempol they should also say Adamis, yet the company is never mentioned and the share price lounges near the $1.00 mark eternally and depressingly. One little article bumps the competition up 500 to 1000% in 2 days but our legitimate progress doesn't get credited to the company and so maybe we accidentally pick up a few % on the day, big whoop... we should be seeing the kind of gains that the competition gets for substantially more insignificant announcements.

Why? Is the NIH instructed to avoid mention of the Adamis name so our PPS doesn't shoot up like the competition? Are we being manipulated in preparation for acquisition? Who knows. But meanwhile, it makes for another terrible day while others get the glory our little company rightfully deserves.